Rare diseases
Investigational molecules
Locations
Study on Preoperative Immunotherapy with Atezolizumab and Tiragolumab for Patients with Colorectal Liver Metastases
GermanyStudy of Ifinatamab Deruxtecan with Atezolizumab and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer
FranceStudy of Fecal Microbiota Transplantation combined with atezolizumab and bevacizumab in patients with unresectable liver cancer who progressed after initial treatment
ItalyStudy on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer
NorwayStudy on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis
FranceStudy of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer
ItalyStudy on Atezolizumab with FOLFOX for Stage III Colon Cancer with Deficient DNA Mismatch Repair
GermanyStudy of Vemurafenib, Cobimetinib, and Atezolizumab for Patients with High-Risk, Surgically Removable BRAF Mutated and Wild-Type Melanoma
ItalyStudy on Atezolizumab, Amivantamab, and Futibatinib for Patients with Advanced Solid Tumors
FranceStudy on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer
AustriaStudy on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients
PortugalStudy of Drug Combination for Advanced Cancer Patients with Known Molecular Profile - FINPROVE Study
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
